Retirement Wealth Solutions’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.97K Buy
71
+7
+11% +$362 ﹤0.01% 340
2026
Q1
$3.25K Buy
64
+20
+45% +$933 ﹤0.01% 396
2025
Q4
$1.3K Buy
44
+6
+16% +$163 ﹤0.01% 536
2025
Q3
$982 Buy
+38
New +$1.06K ﹤0.01% 565

Other funds holding MRNA

Retirement Wealth Solutions's MRNA Position: Q2 2026 in Review

Retirement Wealth Solutions increased its Moderna (MRNA) stake by 11% in Q2 2026, buying an estimated $362 and bringing the position to 71 shares worth $4.97K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Retirement Wealth Solutions first reported a position in MRNA in Q3 2025 and has held it in 4 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Retirement Wealth Solutions held 71 shares of Moderna worth $4.97K as of Q2 2026.
  • Retirement Wealth Solutions bought 7 Moderna shares in Q2 2026, an estimated $362.
  • Moderna made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q2 2026, its #340 holding.
  • Retirement Wealth Solutions first reported a position in Moderna in Q3 2025 and has held it in 4 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.